Logo image of SHPH

SHUTTLE PHARMACEUTICALS HOLD (SHPH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SHPH - US8256934014 - Common Stock

2.5 USD
+0.14 (+5.93%)
Last: 1/23/2026, 8:00:02 PM
2.38 USD
-0.12 (-4.8%)
Pre-Market: 1/26/2026, 8:43:22 AM
Fundamental Rating

0

Taking everything into account, SHPH scores 0 out of 10 in our fundamental rating. SHPH was compared to 525 industry peers in the Biotechnology industry. SHPH has a bad profitability rating. Also its financial health evaluation is rather negative. SHPH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • SHPH had negative earnings in the past year.
  • In the past year SHPH has reported a negative cash flow from operations.
  • In the past 5 years SHPH always reported negative net income.
  • In the past 5 years SHPH always reported negative operating cash flow.
SHPH Yearly Net Income VS EBIT VS OCF VS FCFSHPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

  • SHPH has a Return On Assets of -302.20%. This is amonst the worse of the industry: SHPH underperforms 91.43% of its industry peers.
  • Looking at the Return On Equity, with a value of -767.95%, SHPH is doing worse than 77.90% of the companies in the same industry.
Industry RankSector Rank
ROA -302.2%
ROE -767.95%
ROIC N/A
ROA(3y)-170.32%
ROA(5y)-174.67%
ROE(3y)-496.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SHPH Yearly ROA, ROE, ROICSHPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • SHPH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SHPH Yearly Profit, Operating, Gross MarginsSHPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

  • SHPH has more shares outstanding than it did 1 year ago.
  • SHPH has a worse debt/assets ratio than last year.
SHPH Yearly Shares OutstandingSHPH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50K 100K 150K
SHPH Yearly Total Debt VS Total AssetsSHPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • Based on the Altman-Z score of -25.87, we must say that SHPH is in the distress zone and has some risk of bankruptcy.
  • SHPH's Altman-Z score of -25.87 is on the low side compared to the rest of the industry. SHPH is outperformed by 85.33% of its industry peers.
  • A Debt/Equity ratio of 0.30 indicates that SHPH is not too dependend on debt financing.
  • SHPH has a worse Debt to Equity ratio (0.30) than 68.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z -25.87
ROIC/WACCN/A
WACCN/A
SHPH Yearly LT Debt VS Equity VS FCFSHPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

  • A Current Ratio of 1.66 indicates that SHPH should not have too much problems paying its short term obligations.
  • The Current ratio of SHPH (1.66) is worse than 79.05% of its industry peers.
  • A Quick Ratio of 1.66 indicates that SHPH should not have too much problems paying its short term obligations.
  • SHPH has a worse Quick ratio (1.66) than 78.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.66
SHPH Yearly Current Assets VS Current LiabilitesSHPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 9.87% over the past year.
EPS 1Y (TTM)9.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • SHPH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SHPH Price Earnings VS Forward Price EarningsSHPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SHPH Per share dataSHPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20 -25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for SHPH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

SHUTTLE PHARMACEUTICALS HOLD / SHPH FAQ

What is the ChartMill fundamental rating of SHUTTLE PHARMACEUTICALS HOLD (SHPH) stock?

ChartMill assigns a fundamental rating of 0 / 10 to SHPH.


What is the valuation status for SHPH stock?

ChartMill assigns a valuation rating of 0 / 10 to SHUTTLE PHARMACEUTICALS HOLD (SHPH). This can be considered as Overvalued.


Can you provide the profitability details for SHUTTLE PHARMACEUTICALS HOLD?

SHUTTLE PHARMACEUTICALS HOLD (SHPH) has a profitability rating of 0 / 10.